Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Southern XP IP Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (99)
Prescription medicine registration (9)
Cancellation by sponsor (2)

Date

2025 (6)
2024 (12)
2023 (18)
2022 (8)
2021 (3)
2020 (3)
2019 (22)
2017 (12)
2014 (2)
2013 (12)
2011 (2)
2010 (4)
2008 (2)
2007 (2)
2005 (1)
2001 (1)

Search

Sponsor content

110 result(s) found, displaying 61 to 70

CEFUROXIME SXP cefuroxime (as sodium) 750 mg powder for injection vial (310373)

14 November 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CEFUROXIME SXP cefuroxime (as sodium) 750 mg powder for injection vial.
CEFUROXIME SXP cefuroxime (as sodium) 1500 mg powder for injection vial (310375)

14 November 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CEFUROXIME SXP cefuroxime (as sodium) 1500 mg powder for injection vial.
LORAZE lorazepam 0.5 mg tablet blister pack (304314)

22 July 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LORAZE lorazepam 0.5 mg tablet blister pack.
LORAZE lorazepam 2.5 mg tablet blister pack (304316)

22 July 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LORAZE lorazepam 2.5 mg tablet blister pack.
LORAZE lorazepam 1 mg tablet blister pack (304315)

22 July 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LORAZE lorazepam 1 mg tablet blister pack.
LORAZEPAM SCP lorazepam 1 mg tablet blister pack (304309)

22 July 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LORAZEPAM SCP lorazepam 1 mg tablet blister pack.
LORAZEPAM SCP lorazepam 0.5 mg tablet blister pack (304308)

22 July 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LORAZEPAM SCP lorazepam 0.5 mg tablet blister pack.
LORAZEPAM SCP lorazepam 2.5 mg tablet blister pack (304310)

22 July 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LORAZEPAM SCP lorazepam 2.5 mg tablet blister pack.
DEFERASIROX TLB, DEFERASIROX SIP, DEFERASIROX ANS (Southern XP IP Pty Ltd)

1 July 2021

Prescription medicine registration

Active ingredients: deferasirox.
CIZINATE cinnarizine 20 mg / dimenhydrinate 40 mg uncoated tablets blister pack (288566)

8 January 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIZINATE cinnarizine 20 mg / dimenhydrinate 40 mg uncoated tablets blister pack.

Pages

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Page 11
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.